Immunopharmacokinetics of synthetic beta-carotene

Sergeev A.V., Anan'ev V.S., Vakulova L.A., Zhidkova T.A., Mukhammedzhanov S.K., Ramanauskaĭte R.Yu., Tolkachev V.N.
PubMed Id: 1298123
Year: 1992  Volume: 38  Issue: 6  Pages: 27-29
The immunopharmacology and pharmacokinetics of synthetic beta-carotene were studied in complex clinico-laboratory investigations after single and repeated per os administrations of various doses of the drug to healthy volunteers and cancer patients. Repeated treatment with beta-carotene at a dose of 30 mg caused no significant changes in the immunological parameters studied. However, treatment with a dose of 250 mg altered the parameters as follows: alteration of beta-carotene content in blood, elevation of the counts of lymphocytes and T lymphocytes forming 'active' rosettes, increase in the proliferative response of lymphocytes to the mitogen PWM and activation of natural killers. Single administration of the drug in a dose of 1,000 and 2,000 mg led to short-term reversible immunodepression, appeared as leukopenia, abolition of the proliferative response of lymphocytes to mitogens and inhibition of T suppressors. Kinetics of retinoids and beta-carotene content in blood plasma was studied after single per os administration of drug megadoses.
Download PDF:  

Sergeev, A. V., Anan'ev, V. S., Vakulova, L. A., Zhidkova, T. A., Mukhammedzhanov, S. K., Ramanauskaĭte, R. Yu., Tolkachev, V. N. (1992). Immunopharmacokinetics of synthetic beta-carotene. Voprosy Meditsinskoi Khimii, 38(6), 27-29.
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)